Kiniksa Pharmaceuticals International (KNSA) Operating Margin Growth (5y) (2026)
Kiniksa Pharmaceuticals International (KNSA) Operating Margin Growth (5y) (2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.50 Bn | 39.84 Bn | 2.15 Bn |
| 3 | Zoetis | 32.42 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.99 Bn | 19.33 Bn | 683.80 Mn |
| 6 | Viatris | 18.96 Bn | 18.08 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.15 Bn | 5.62 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53,758.00 |